199 related articles for article (PubMed ID: 29310685)
1. What are the main inefficiencies in trial conduct: a survey of UKCRC registered clinical trials units in the UK.
Duley L; Gillman A; Duggan M; Belson S; Knox J; McDonald A; Rawcliffe C; Simon J; Sprosen T; Watson J; Wood W
Trials; 2018 Jan; 19(1):15. PubMed ID: 29310685
[TBL] [Abstract][Full Text] [Related]
2. Using digital tools in the recruitment and retention in randomised controlled trials: survey of UK Clinical Trial Units and a qualitative study.
Blatch-Jones A; Nuttall J; Bull A; Worswick L; Mullee M; Peveler R; Falk S; Tape N; Hinks J; Lane AJ; Wyatt JC; Griffiths G
Trials; 2020 Apr; 21(1):304. PubMed ID: 32245506
[TBL] [Abstract][Full Text] [Related]
3. Where do we go from here? - Opportunities and barriers to the career development of trial managers: a survey of UK-based trial management professionals.
Mitchell E; Goodman K; Hartley S; Hickey H; McDonald AM; Meadows HM; Rhodes S; Taylor J; Wakefield N; Farrell B;
Trials; 2020 May; 21(1):384. PubMed ID: 32375851
[TBL] [Abstract][Full Text] [Related]
4. Identifying research priorities for effective retention strategies in clinical trials.
Kearney A; Daykin A; Shaw ARG; Lane AJ; Blazeby JM; Clarke M; Williamson P; Gamble C
Trials; 2017 Aug; 18(1):406. PubMed ID: 28859674
[TBL] [Abstract][Full Text] [Related]
5. The trials methodological research agenda: results from a priority setting exercise.
Tudur Smith C; Hickey H; Clarke M; Blazeby J; Williamson P
Trials; 2014 Jan; 15():32. PubMed ID: 24456928
[TBL] [Abstract][Full Text] [Related]
6. Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) review.
Cook JA; Hislop J; Adewuyi TE; Harrild K; Altman DG; Ramsay CR; Fraser C; Buckley B; Fayers P; Harvey I; Briggs AH; Norrie JD; Fergusson D; Ford I; Vale LD
Health Technol Assess; 2014 May; 18(28):v-vi, 1-175. PubMed ID: 24806703
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Patient and public involvement (PPI) in UK surgical trials: a survey and focus groups with stakeholders to identify practices, views, and experiences.
Crocker JC; Pratt-Boyden K; Hislop J; Rees S; Locock L; Olszowski S; Chant A; Treweek S; Cook JA; Woolfall K; Farrar N; Bostock J; Bulbulia R
Trials; 2019 Feb; 20(1):119. PubMed ID: 30744684
[TBL] [Abstract][Full Text] [Related]
9. UK publicly funded Clinical Trials Units supported a controlled access approach to share individual participant data but highlighted concerns.
Hopkins C; Sydes M; Murray G; Woolfall K; Clarke M; Williamson P; Tudur Smith C
J Clin Epidemiol; 2016 Feb; 70():17-25. PubMed ID: 26169841
[TBL] [Abstract][Full Text] [Related]
10. Monitoring in practice - How are UK academic clinical trials monitored? A survey.
Love SB; Yorke-Edwards V; Lensen S; Sydes MR
Trials; 2020 Jan; 21(1):59. PubMed ID: 31918743
[TBL] [Abstract][Full Text] [Related]
11. Conducting qualitative research within Clinical Trials Units: avoiding potential pitfalls.
Cooper C; O'Cathain A; Hind D; Adamson J; Lawton J; Baird W
Contemp Clin Trials; 2014 Jul; 38(2):338-43. PubMed ID: 24937019
[TBL] [Abstract][Full Text] [Related]
12. Digital tools for the recruitment and retention of participants in randomised controlled trials: a systematic map.
Frampton GK; Shepherd J; Pickett K; Griffiths G; Wyatt JC
Trials; 2020 Jun; 21(1):478. PubMed ID: 32498690
[TBL] [Abstract][Full Text] [Related]
13. A survey of facilitators and barriers to recruitment to the MAGNETIC trial.
Kaur G; Smyth RL; Powell CV; Williamson P
Trials; 2016 Dec; 17(1):607. PubMed ID: 28010731
[TBL] [Abstract][Full Text] [Related]
14. Learning from OCTET - exploring the acceptability of clinical trials management methods.
Arundel C; Gellatly J
Trials; 2018 Jul; 19(1):378. PubMed ID: 30005659
[TBL] [Abstract][Full Text] [Related]
15. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
16. Project management lessons learned from the multicentre CYCLE pilot randomized controlled trial.
McCaskell DS; Molloy AJ; Childerhose L; Costigan FA; Reid JC; McCaughan M; Clarke F; Cook DJ; Rudkowski JC; Farley C; Karachi T; Rochwerg B; Newman A; Fox-Robichaud A; Herridge MS; Lo V; Feltracco D; Burns KE; Porteous R; Seely AJE; Ball IM; Seczek A; Kho ME
Trials; 2019 Aug; 20(1):532. PubMed ID: 31455384
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness and acceptability of multimedia information when recruiting children and young people to trials: the TRECA meta-analysis of SWATs.
Knapp P; Martin-Kerry J; Moe-Byrne T; Sheridan R; Coleman E; Roche J; Young B; Higgins S; Preston J; Bower P; Gamble C; Stones C
Health Soc Care Deliv Res; 2023 Nov; 11(24):1-112. PubMed ID: 38140894
[TBL] [Abstract][Full Text] [Related]
18. Resource implications of preparing individual participant data from a clinical trial to share with external researchers.
Tudur Smith C; Nevitt S; Appelbe D; Appleton R; Dixon P; Harrison J; Marson A; Williamson P; Tremain E
Trials; 2017 Jul; 18(1):319. PubMed ID: 28712359
[TBL] [Abstract][Full Text] [Related]
19. Comparative costs and activity from a sample of UK clinical trials units.
Hind D; Reeves BC; Bathers S; Bray C; Corkhill A; Hayward C; Harper L; Napp V; Norrie J; Speed C; Tremain L; Keat N; Bradburn M
Trials; 2017 May; 18(1):203. PubMed ID: 28464930
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
